GlassScriptPhysician profile
John N Schuen
NPI 1720054737
$1,961.17
in general payments reported to CMS, 2019-2025
23 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $161 · 2021: $302 · 2022: $650 · 2023: $169 · 2024: $244 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $614.49 | 2019-2025 | Trikafta |
| Mylan Specialty L.P. | $175.99 | 2022-2023 | Tobi Podhaler |
| Chiesi USA, INC. | $139.64 | 2020-2021 | |
| Zoll Respicardia, INC. | $136.53 | 2019 | |
| Harmony Biosciences LLC | $118.61 | 2022-2024 | |
| Jazz Pharmaceuticals INC. | $104.87 | 2022 | |
| Resmed Corp | $82.44 | 2019-2021 | |
| Philips North America LLC | $71.32 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $70.64 | 2022-2025 | Hyqvia |
| Gilead Sciences, INC. | $62.31 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $56.17 | 2022 | |
| Aimmune Therapeutics, INC. | $49.46 | 2024 | |
| Pari Respiratory Equipment, INC. | $44.41 | 2020-2024 | Kitabis Pak |
| Pharming Healthcare, INC. | $39.58 | 2023-2024 | Ruconest |
| Ambu INC. | $36.73 | 2024-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $24.29 | 2021 | |
| Digestive Care, INC. | $24.01 | 2024 | Pertzye |
| Vivus LLC | $22.65 | 2024 | Qsymia |
| Breas Medical, INC. | $19.69 | 2024 | Vivo 45 Ls |
| Baxter Healthcare | $18.75 | 2024 | Hillrom - Volara System |
| Genentech USA, INC. | $17.37 | 2022 | |
| Vapotherm INC | $15.91 | 2021 | |
| Genzyme Corporation | $15.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schuen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.